Avoidance of Harm From Treatment for ANCA-Associated Vasculitis

Purpose of review With established immunosuppressant treatment regimens for anti-neutrophil cytoplasm antibody-associated vasculitides (AAV), prognosis has significantly improved. The mainstay of treatment still comprises high-dose corticosteroids and cyclophosphamide for severe forms, although ritu...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Catherine, Harper, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Vasculitis (C Pagnoux and M Walsh, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694500/
https://www.ncbi.nlm.nih.gov/pubmed/29201630
http://dx.doi.org/10.1007/s40674-017-0082-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694500/
https://www.ncbi.nlm.nih.gov/pubmed/29201630
http://dx.doi.org/10.1007/s40674-017-0082-y

Ejemplares similares